Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Towa’s Shipment Restriction List Now Expands to 352 Products
August 16, 2021
- Evrysdi, Aimovig Now Available; Veklury’s Normal Distribution to Start around October
August 13, 2021
- Hisamitsu Ordered to Suspend Biz over Salonpas OTC Data Tampering
August 13, 2021
- Lenvima Plus Keytruda Approved for RCC in US
August 13, 2021
- Reps’ Face-to-Face Meetings Remain Flat YOY in June; Growth Seen across All Channels from May: Intage
August 13, 2021
- Morimoto Pharma Aims at Commercial Production of Freeze-Dried Vaccine in FY2022
August 12, 2021
- Japan Ethical Drug Sales Rise 2.1% in June: Crecon
August 12, 2021
- Ex-HBS Dean Nitin Nohria Tapped as Board Chair at Rakuten Medical
August 12, 2021
- Cost-Effectiveness Simulation Model Developed for Type 2 Diabetes: Novo
August 12, 2021
- Orizuru Therapeutics Boots Up to Take Over iPSC Assets from T-CiRA, Eyes IPO in 2026
August 11, 2021
- Santen Snags EMEA Rights to Sydnexis’ Myopia Drug
August 11, 2021
- Daiichi Sankyo’s Enhertu Beats Kadcyla in 2nd-Line Breast Cancer
August 11, 2021
- Meiji Distributing AstraZeneca’s COVID-19 Vaccine in Japan
August 11, 2021
- Healios Bolsters Capital Alliance with Athersys, Gets Manufacturing License for Cell Therapy Product
August 10, 2021
- Vitrakvi Oral Solution Now Available in Japan: Bayer
August 10, 2021
- Pfizer Japan Announces Shipment Curbs, Stockouts for 9 Products in Knock-On Effect
August 10, 2021
- Otsuka’s 4 Global Brands Likely to Hit 480 Billion Yen, 2 Years Earlier
August 10, 2021
- HIF-PH Drugs’ Sluggish Q1 Sales Signal Tepid Uptake as Side Effect Concerns Weigh
August 10, 2021
- Foreign Drug Makers Scrapping Sales Offices as Sanofi Follows GSK, Novartis, AZ
August 6, 2021
- Kissei Sublicenses Fostamatinib to Chinese Firm
August 6, 2021
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…